Notice Number: NOT-OD-15-059
Release Date: January 22, 2015 (Rescinded July 23, 2018)
National Institutes of Health (NIH)
The purpose of this Notice is to remind applicants that the basic requirements for allowable applications have not changed with the updated NIH/AHRQ policy on application submission (see NOT-OD-14-074 and NOT-OD-14-082). Investigators now may submit a New Application, following an unsuccessful application, without concern for scientific overlap with previously reviewed applications.
A New Application is an application that has not been previously proposed or received funding. Whether it follows an unsuccessful application or not, a New Application is neither a Resubmission Application nor a Renewal Application, and must comply with the rules for a New Application.
The following content is NOT allowed anywhere in a New Application or its associated components (e.g., the appendix, letters of support, other attachments):
A New Application that does not conform to the rules for a New Application will not be reviewed and will not be considered for funding. This means that:
A phase II Small Business Innovation Research/Small Business Technology Transfer Research (SBIR/STTR) application following a funded phase I SBIR/STTR application is a Renewal Application. As for other Renewal Applications, these phase II SBIR/STTR applications are allowed two submissions: a New phase II application and Resubmission phase II application.
Please see our Frequently Asked Questions Resources for additional information:
FAQs on Resubmission of NIH Applications
Please direct all inquiries to:
Division of Receipt and Referral
NIH Center for Scientific Review (CSR)
NIH Review Policy Officer
Gerald E. (Jerry) Calderone, Ph.D.
Agency for Healthcare Research and Quality